Trials / Completed
CompletedNCT00325962
A Study of the Effects of 6R-BH4 on Blood Pressure in Subjects With Poorly Controlled Systemic Hypertension
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Study of the Effects of 6R-BH4 on Blood Pressure in Subjects With Poorly Controlled Systemic Hypertension
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 84 (planned)
- Sponsor
- BioMarin Pharmaceutical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether 6R-BH4 (sapropterin dihydrochloride) is safe and effective in the treatment of poorly controlled hypertension in the presence or absence of type 2 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 6R-BH4 (sapropterin dihydrochloride) |
Timeline
- Start date
- 2006-05-01
- Primary completion
- 2006-12-01
- Completion
- 2008-12-01
- First posted
- 2006-05-15
- Last updated
- 2009-07-21
Locations
24 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00325962. Inclusion in this directory is not an endorsement.